Two Sigma Securities’s Alaunos Therapeutics TCRT Stock Holding History

Two Sigma Securities’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,023	Closed	-$7.15K	–	3609
2024 Q2	$7.15K	Buy	+1,023	New	+$12.2K	﹤0.01%	2843
2024 Q1	–	Sell	-1,175	Closed	-$12.5K	–	3632
2023 Q4	$12.5K	Buy	1,175 +891	+314%	+$10.7K	﹤0.01%	2794
2023 Q3	$5.62K	Buy	+284	New	+$12.2K	﹤0.01%	2775
2022 Q4	–	Sell	-342	Closed	-$88K	–	3245
2022 Q3	$88K	Buy	+342	New	+$99.3K	﹤0.01%	2114
2022 Q1	–	Sell	-419	Closed	-$68K	–	2498
2021 Q4	$68K	Buy	419 +183	+78%	+$40.2K	﹤0.01%	1231
2021 Q3	$64K	Buy	+236	New	+$72.2K	﹤0.01%	1360
2021 Q1	–	Sell	-81	Closed	-$31K	–	1688
2020 Q4	$31K	Buy	+81	New	+$32.2K	﹤0.01%	1582

Other funds holding TCRT

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

SWM

Sugarloaf Wealth Management Duluth, Georgia $529M AUM 14.14% 1-Year Est. Return

Two Sigma Securities's TCRT Position: Q3 2024 in Review

Two Sigma Securities sold out of Alaunos Therapeutics (TCRT) in Q3 2024, closing a stake of 1,023 shares — an estimated $7.15K sold.

Two Sigma Securities first reported a position in TCRT in Q4 2020 and held it in 7 quarters. The position peaked at $88K in Q3 2022. 29 funds tracked by Wall St. Rank hold TCRT as of Q3 2024.

Two Sigma Securities reported no remaining Alaunos Therapeutics position as of Q3 2024 after selling out during the quarter.
Two Sigma Securities sold 1,023 Alaunos Therapeutics shares in Q3 2024, an estimated $7.15K.
Two Sigma Securities first reported a position in Alaunos Therapeutics in Q4 2020 and held it in 7 quarters.
Two Sigma Securities's Alaunos Therapeutics position peaked at $88K in Q3 2022.
29 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2024.

Based on Two Sigma Securities's 13F filing for Q3 2024, filed 14 Nov 2024.